Stay updated on Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Enrollment is updated to 959 participants and the study's last update is posted on 2025-08-11. Primary completion is 2025-03-20 and estimated study completion is 2025-09-30.
    Difference
    0.1%
    Check dated 2025-11-01T23:53:44.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Difference
    1%
    Check dated 2025-10-04T02:47:58.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Page content is updated to revision v3.1.0 and several MedlinePlus topics are removed; overall, no substantial new information is added and core content remains unchanged.
    Difference
    0.2%
    Check dated 2025-09-27T02:04:45.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Minor update: version bumped from v3.0.1 to v3.0.2 and the Back to Top element was removed; core content remains unchanged.
    Difference
    0.1%
    Check dated 2025-09-12T17:13:30.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The location name has been updated from 'Tuen Mun, Hong Kong' to 'Tuenmen, Hong Kong', and the version number has changed from v3.0.0 to v3.0.1.
    Difference
    0.1%
    Check dated 2025-09-05T13:48:35.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of numerous location details across various countries, particularly in Europe, Asia, and South America, as well as the introduction of new medical topics related to drug safety. Several outdated location entries have been removed, streamlining the content.
    Difference
    23%
    Check dated 2025-08-29T08:13:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page.